自体脂肪移植用于美容性乳房增大:系统综述与荟萃分析
结果显示患者和医生满意度分别高达93%和87%,仅需1.56次手术即可达到理想效果,1年随访长期存活率约60%至70%,临床并发症发生率仅8%,癌症报告2例(0.04%)。
要点
- 自体脂肪移植美容性乳房增大患者满意度93%、医生满意度87%,平均仅需1.56次手术。
- 1年随访脂肪长期存活率约60%至70%,临床并发症发生率仅8%。
- 5162例中仅报告2例癌症(0.04%),5%患者因异常发现需活检。
核心结论
- 自体脂肪移植似乎是美容性乳房增大的主要工具,术前患者选择至关重要但报告不足,未来研究应关注影响脂肪存活率的技术与患者因素及肿瘤学安全性。
研究设计与样本
- 纳入研究证据等级较低(2b至5级),荟萃分析包括17项前瞻性队列研究、4项回顾性队列研究、6项病例对照研究和38项病例系列。
- 发表文章来自21个国家。
主要发现
- 手术指征为美容性增大占93.2%,先天性畸形占6.8%。
- 5162例患者中报告2例癌症(0.04%)。
- 荟萃分析显示患者满意率93%、医生满意率87%,总体仅需1.56次手术即可达到理想效果。
- 1年随访计算长期存活率约60%至70%。
- 仅8%手术出现临床并发症,5%患者因临床或影像学异常发现需活检。
临床怎么用
- 自体脂肪移植可用于美容性乳房增大,患者和医生满意度高、并发症率低,但需重视术前患者选择。
局限性
- 大多数研究证据等级较低(2b至5级)。
- 术前患者选择至关重要但报告不足。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Autologous fat transplantation has already become a part of clinical practice for aesthetic breast augmentation even though evidence regarding its efficacy is still lacking. OBJECTIVES: The authors sought to determine the current worldwide status and efficacy, techniques, and oncologic safety on this subject. METHODS: PubMed, EMBASE, and Cochrane Library databases were searched to identify all relevant studies. RESULTS: Eighty-four articles published between 1987 and April 2020, consisting of 6468 patients, were included, and 64 studies consisting of 5162 unique patients were included in the meta-analysis. Most studies had a low level of evidence (levels 2b-5); In this meta-analysis, there were 17 prospective cohort studies, 4 retrospective cohort studies, 6 case-control studies, and 38 case series. The publications were from 21 countries. Indications for autologous fat transplantation were aesthetic augmentation (93.2%) and congenital malformation (6.8%). Among the 5162 patients, 2 cases (0.04%) of cancer were reported. The meta-analysis revealed very high overall patient and surgeon satisfaction rates of 93% and 87%, respectively. Overall, only 1.56 sessions were needed to achieve the desired result. Long-term survival was calculated to be approximately 60% to 70% at 1-year follow-up. Only 8% of procedures resulted in clinical complications, and 5% of patients required biopsy because of abnormal clinical or radiological findings. CONCLUSIONS: Autologous fat transplantation seems to be a major tool in aesthetic breast augmentation. Preoperative patient selection is essential but under-reported. Future research should focus on evaluating the technical and patient factors influencing the rate of fat survival and its oncological safety.
引用
- Wu Y, Hu F, Li X, et al. Autologous Fat Transplantation for Aesthetic Breast Augmentation: A Systematic Review and Meta-Analysis. Aesthet Surg J. 2021. PMID: 33655292. doi:10.1093/asj/sjaa364
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。